Table 1.
Year groups |
Concomitant HCV and/or HCC |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
All (261) | 1988–2000 (77) | 2001–2006 (86) | 2007–2011 (98) | P | Alcohol (129) | With HCV (64) | With HCC (32) | With HCV+HCC (36) | P | |
Age | 53 ± 8 | 50 ± 8 | 53 ± 8 | 55 ± 7 | 0.066 | 53 ± 8 | 50 ± 7 | 60 ± 6 | 55 ± 5 | <0.0001 |
% Males | 206 (79) | 56 (73) | 74 (86) | 76 (78) | 0.1 | 91 (71) | 54 (84) | 28 (88) | 33 (92) | 0.009 |
Alcohol g/d | 83 ± 57 | 89 ± 65 | 87 ± 54 | 74 ± 52 | 0.85 | 88 ± 61 | 83 ± 55 | 84 ± 63 | 63 ± 38 | 0.1 |
Dialysis (%) | 28 (11) | 2 (3) | 14 (17) | 12 (13) | 0.015 | 20 (16) | 6 (9) | 2 (7) | 0 (0) | 0.044 |
MELD | 19 ± 8 | 18 ± 7 | 19 ± 8 | 19 ± 8 | 0.045 | 21 ± 8 | 21 ± 9 | 14 ± 6 | 13 ± 4 | <0.0001 |
Albumin | 3.3 ± 0.57 | 3.1 ± 0.56 | 3.3 ± 0.53 | 3.4 ± 0.58 | 0.39 | 3.2 ± 0.6 | 3.2 ± 0.6 | 3.3 ± 0.5 | 3.4 ± 0.5 | 0.47 |
Sodium | 136 ± 5 | 136 ± 5 | 136 ± 5 | 136 ± 4 | 0.78 | 136 ± 5 | 136 ± 5 | 136 ± 5 | 137 ± 3 | 0.51 |
MELD, model end-stage liver disease.